Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

See-Tarn Woon

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
Clinical Pediatrics|August 21, 2010
Fulminant mulch pneumonitis in undiagnosed chronic granulomatous disease: a medical emergencyRohan Ameratunga, See-Tarn Woon, Julian Vyas, et al.
Critical Reviews in Food Science and Nutrition|August 28, 2014
Health Risks and Adverse Reactions to Functional FoodsRohan Ameratunga, Christine Crooks, Greg Simmons, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|June 10, 2010
The clinical utility of molecular diagnostic testing for primary immune deficiency disorders: a case based reviewRohan Ameratunga, See-Tarn Woon, Katherine Neas, et al.
Expert Review of Clinical Immunology|January 14, 2014
New diagnostic criteria for CVIDRohan Ameratunga, See-Tarn Woon, David Gillis, et al.
Pathology|December 23, 2009
IgE-type multiple myeloma with the late development of IgA2 kappa and plasma cell leukaemiaWeldon Chiu, Humphrey Pullon, See-Tarn Woon, et al.
Expert Review of Clinical Immunology|December 2, 2015
Application of diagnostic and treatment criteria for common variable immunodeficiency disorderRohan Ameratunga, Peter Storey, Russell Barker, et al.
Expert Review of Clinical Immunology|May 29, 2018
Keeping it in the family: the case for considering late-onset combined immunodeficiency a subset of common variable immunodeficiency disordersRohan Ameratunga, Yeri Ahn, Anthony Jordan, et al.
Frontiers in Immunology|September 15, 2025
Opinion: the evolving understanding of polygenic common variable immunodeficiency-like disordersRohan Ameratunga, Euphemia Yee Leung, Hilary J Longhurst, et al.
Clinical Immunology (Orlando, Fla.)|July 18, 2024
Limitations in the clinical utility of vaccine challenge responses in the evaluation of primary antibody deficiency including Common Variable Immunodeficiency DisordersRohan Ameratunga, Hilary Longhurst, Euphemia Leung, et al.
Oncology Research|June 21, 2006
Inhibition of DMXAA-induced tumor necrosis factor production in murine splenocyte cultures by NF-kappaB inhibitorsLiang-Chuan S Wang, See-Tarn Woon, Bruce C Baguley, et al.
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Clinical Pediatrics|August 21, 2010
Fulminant mulch pneumonitis in undiagnosed chronic granulomatous disease: a medical emergencyRohan Ameratunga, See-Tarn Woon, Julian Vyas, et al.
Critical Reviews in Food Science and Nutrition|August 28, 2014
Health Risks and Adverse Reactions to Functional FoodsRohan Ameratunga, Christine Crooks, Greg Simmons, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|June 10, 2010
The clinical utility of molecular diagnostic testing for primary immune deficiency disorders: a case based reviewRohan Ameratunga, See-Tarn Woon, Katherine Neas, et al.
Expert Review of Clinical Immunology|January 14, 2014
New diagnostic criteria for CVIDRohan Ameratunga, See-Tarn Woon, David Gillis, et al.
Pathology|December 23, 2009
IgE-type multiple myeloma with the late development of IgA2 kappa and plasma cell leukaemiaWeldon Chiu, Humphrey Pullon, See-Tarn Woon, et al.
Expert Review of Clinical Immunology|December 2, 2015
Application of diagnostic and treatment criteria for common variable immunodeficiency disorderRohan Ameratunga, Peter Storey, Russell Barker, et al.
Expert Review of Clinical Immunology|May 29, 2018
Keeping it in the family: the case for considering late-onset combined immunodeficiency a subset of common variable immunodeficiency disordersRohan Ameratunga, Yeri Ahn, Anthony Jordan, et al.
Frontiers in Immunology|September 15, 2025
Opinion: the evolving understanding of polygenic common variable immunodeficiency-like disordersRohan Ameratunga, Euphemia Yee Leung, Hilary J Longhurst, et al.
Clinical Immunology (Orlando, Fla.)|July 18, 2024
Limitations in the clinical utility of vaccine challenge responses in the evaluation of primary antibody deficiency including Common Variable Immunodeficiency DisordersRohan Ameratunga, Hilary Longhurst, Euphemia Leung, et al.
Oncology Research|June 21, 2006
Inhibition of DMXAA-induced tumor necrosis factor production in murine splenocyte cultures by NF-kappaB inhibitorsLiang-Chuan S Wang, See-Tarn Woon, Bruce C Baguley, et al.
Pageof 7